Popular Articles

Legalised Euthanasia Is Not Detrimental To Palliative Care
Assisted dying laws do not mean that fewer people use palliative care, according to a study published on bmj.com today.
generic viagra online
NOSCAR(R) Announces NOTES(R) Multicenter Human Trials In The U.S.
The Natural Orifice Surgery Consortium for Assessment and Research(R) (NOSCAR(R)), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announces the first Natural Orifice Translumenal Endoscopic Surgery(R) (NOTES(R)) multicenter human trial in the United States. Until now, NOSCAR research efforts have focused on basic research. The next phase will involve critical human trials. Continuing research commitments from industry partners Ethicon Endo-Surgery, Olympus America Inc. and Stryker Medical will provide funds to support the study in this emerging transdisciplinary therapy. The landmark study was announced at the 4th International Conference on NOTES in Boston where nearly 300 physicians and industry representatives gathered to learn the latest information about the science and technology of the medical platform.
News of the day
FDA Approves VYVANSE CII Label Change To Include Supplementary Clinical Data Supporting Efficacy At 13 Hours Postdose In Children Age 6-12 With ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment VYVANSE® (lisdexamfetamine dimesylate) CII, to include supplemental data that demonstrated significant ADHD symptom control in children aged 6 to 12 from the first time point measured (1.5 hours) through 13 hours postdose. VYVANSE is now the first and only oral ADHD stimulant treatment to have 13-hour postdose efficacy data for pediatric patients included in its product labeling.
Cardiovascular

Study Finds Evidence Of Malaria Origins, Could Lead To Vaccine Development

"Malaria may have jumped to humans from chimpanzees much as AIDS did, U.S. researchers reported on Monday in a [Proceedings of the National Academy of Sciences] study they hope could help in developing a vaccine against the infection," Reuters reports. The researchers found evidence the Plasmodium falciparum parasite that "causes most cases of malaria is a close genetic relative of a parasite found in chimpanzees," the news service writes (8/4). According to the Mail Online, chimpanzees are known to harbor the Plasmodium reichenowi parasite, which is closely related to P. falciparum. Although most researchers assumed these parasites co-existed separately in humans and chimpanzees for the last five million years, "the new research shows the chimp parasites are wide-ranging, indicating malaria went from animals to humans in much the way HIV, SARS and swine flu did. It suggests P. falciparum evolved from P. reichenowi," the publication writes. "Discovery of these parasites shows a broader range of relatives to the human parasite, some of which might provide key insights in drug development or act as vaccines that may help prevent human malaria," said Francisco Ayala, an evolutionary biologist, and lead author on the study, (8/4). The other lead author Nathan Wolfe, of Stanford University and the Global Viral Forecasting Initiative, said, "It is now clear that a new disease that successfully jumps from an animal to a human can last not just for decades, but millennia or more," the Associated Press reports. As a result, the "task of stopping future disease spillovers from animals to humans vital, not only for saving lives today, but for the health of people for many generations to come," he said. According to Wolfe, a better understanding of the chimp parasites could lead to improved malaria medicine or the development of a vaccine. He noted that early smallpox vaccines were developed from the related cowpox. The research was funded by the National Institutes of Health, Tufts University and the National Geographic Society (Schmid, 8/3). National Geographic (Avasthi, 8/3) and NPR (Hamilton, 8/3) also covered the story. This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):